GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA), relating to its proposed sale to Fall Line Capital LLC. Under the terms of the agreement, GRNA shareholders are expected to receive $0.30 in cash per share they own.
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA), relating to its proposed sale to Fall Line Capital LLC. Under the terms of the agreement, GRNA shareholders are expected to receive $0.30 in cash per share they own.